Home
Live Updates
Brainomix Showcases Growing Evidence for its Novel AI-Based Imaging Biomarkers in Lung Fibrosis : comparemela.com
Brainomix Showcases Growing Evidence for its Novel AI-Based Imaging Biomarkers in Lung Fibrosis
The company unveiled a series of new studies highlighting the prognostic value of its imaging biomarkers in patients with fibrotic lung diseaseThe studies reflect the company's expanding Life
Related Keywords
Chicago ,
Illinois ,
United States ,
London ,
City Of ,
United Kingdom ,
Brompton ,
Medway ,
San Diego ,
California ,
Heidelberg ,
Baden Wüberg ,
Germany ,
Ireland ,
American ,
Sue Charles ,
Avalyn Pharma ,
Michalis Papadakis ,
Prnewswire Brainomix ,
Ross Stewart ,
Michael Kreuter ,
Peter George ,
Jeff Wyrtzen ,
Heidelberg University ,
Twitter ,
Lung Center Mainz ,
Marketing Business Development ,
Astrazeneca ,
Senior Business Development ,
Linkedin ,
Facebook ,
American Thoracic Society ,
University Of Oxford ,
Life Science ,
Idiopathic Pulmonary Fibrosis ,
Forced Vital Capacity ,
Prof Dr Michael Kreuter ,
Lung Center ,
Senior Medical Director ,
Clinical Lead ,
Royal Brompton Hospital ,
Senior Business Development Manager ,
Pharma Partnerships ,
Chief Marketing ,
Business Development ,
Ihr Portfolio ,
comparemela.com © 2020. All Rights Reserved.